Nash, Peter http://orcid.org/0000-0002-2571-788X
Article History
First Online: 19 December 2022
Competing interests
: The author declares that he has received grants for research and clinical trials and honoraria for advice and lectures from Abbvie, Amgen, BMS, Gilead/Galapagos, Janssen, Lilly, Novartis, Pfizer and Roche.